Extended follow-up of CD4+ T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine

dc.contributorNottingham University Hospitals NHS Trust
dc.contributorUniversidade Estadual Paulista (UNESP)
dc.contributorUniversity of Nottingham
dc.date.accessioned2022-04-28T19:29:17Z
dc.date.accessioned2022-12-20T01:12:50Z
dc.date.available2022-04-28T19:29:17Z
dc.date.available2022-12-20T01:12:50Z
dc.date.created2022-04-28T19:29:17Z
dc.date.issued2021-02-01
dc.identifierHematological Oncology, v. 39, n. 1, p. 137-140, 2021.
dc.identifier1099-1069
dc.identifier0278-0232
dc.identifierhttp://hdl.handle.net/11449/221542
dc.identifier10.1002/hon.2797
dc.identifier2-s2.0-85090165721
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5401671
dc.languageeng
dc.relationHematological Oncology
dc.sourceScopus
dc.subjectbendamustine
dc.subjectCD4 lymphopenia
dc.subjectchronic lymphocytic leukemia
dc.subjectnon-Hodgkin lymphoma
dc.titleExtended follow-up of CD4+ T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine
dc.typeOtros


Este ítem pertenece a la siguiente institución